 | PEHA - Phapros Tbk. | PEHA - Phapros Tbk. | PEHA - Phapros Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Board | : | 4 Index COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | |
|||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 0 | |
| Rating ROA | 0 | |
| Rating EQUITY | 1 | |
| Rating ROE | 0 | |
| Rating DER | 3 | |
| Rating TOTAL | 0 | |
| MARKET CAPITALIZATION | ||
| Listed Share | 840.000.000 | |
| Price | Rp. 386 | |
| Capitalization | Rp. 324.240.000.000 | |
| OWNERSHIP | ||
| Listing Date : 26-DEC-2018 | ||
| Lokal 97,05 % | Asing 0,04 % | Lainnya 2,91 % |
| PEHA - Phapros Tbk. | PEHA - Phapros Tbk. | PEHA - Phapros Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Board | : | 4 Index COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
Financial Statements
| Description | 2Q19 | 2Q20 | 2Q21 | 2Q22 | 2Q23 | 2Q24 | CAGR 5Y(%) | |
| Last Price | 1890 | 1310 | 1165 | 940 | 670 | 400 | ||
| Market Cap | 1.6 T | 1.1 T | 978.6 B | 789.6 B | 562.8 B | 336.0 B | -79.00 | |
| BALANCE SHEET | ||||||||
| Cash | 43.4 B | 62.0 B | 94.1 B | 31.0 B | 38.2 B | 34.0 B | -21.66 | |
| Total Asset | 1.9 T | 2.1 T | 2.0 T | 1.9 T | 1.8 T | 1.7 T | -10.53 | |
| S.T.Borrowing | 1.1 T | 1.3 T | 1.1 T | 803.8 B | 765.7 B | 723.3 B | ||
| L.T.Borrowing | 106.6 B | 96.2 B | 118.5 B | 343.5 B | 299.9 B | 278.9 B | ||
| Total Equity | 745.5 B | 699.4 B | 737.5 B | 745.4 B | 769.8 B | 720.5 B | -3.35 | |
| INCOME STATEMENT | ||||||||
| Revenue | 552.1 B | 453.9 B | 466.2 B | 565.5 B | 554.9 B | 367.8 B | -33.38 | |
| Gross Profit | 296.4 B | 245.3 B | 238.3 B | 276.4 B | 278.8 B | 162.5 B | -45.18 | |
| Operating Profit | 88.9 B | 60.7 B | 52.5 B | 45.4 B | 40.6 B | -30.5 B | -134.31 | |
| Net.Profit | 47.7 B | 26.9 B | 10.4 B | 11.1 B | 7.7 B | -49.5 B | -203.77 | |
| EBITDA | 109.0 B | 82.2 B | 80.1 B | 71.0 B | 65.2 B | -6.2 B | -105.69 | |
| Interest Expense | 34.0 B | 45.5 B | 39.7 B | 27.3 B | 30.1 B | 31.7 B | ||
| RATIO | ||||||||
| EPS | 56.84 | 32 | 12.41 | 13.26 | 9.22 | -58.88 | -203.59 | |
| PER | 33.25 x | 40.94 x | 93.88 x | 70.89 x | 72.67 x | -6.79 x | ||
| BVPS | 887.54 | 832.67 | 877.94 | 887.33 | 916.4 | 857.71 | ||
| PBV | 2.13 x | 1.57 x | 1.33 x | 1.06 x | 0.73 x | 0.47 x | ||
| ROA | 0.025 | 0.0129 | 0.0053 | 0.0059 | 0.0042 | -0.0287 | -214.80 | |
| ROE | 0.064 | 0.0384 | 0.0141 | 0.0149 | 0.0101 | -0.0687 | -207.34 | |
| EV/EBITDA | 24.87 | 29.38 | 26.29 | 26.84 | 24.39 | -209.95 | ||
| Debt/Equity | 1.56 | 1.97 | 1.65 | 1.54 | 1.38 | 1.39 | ||
| Debt/TotalCap | 0.61 | 0.66 | 0.62 | 0.61 | 0.58 | 0.58 | ||
| Debt/EBITDA | 10.7 | 16.75 | 15.24 | 16.16 | 16.35 | -161.33 | ||
| EBITDA/IntExps | 3.21 | 1.81 | 2.02 | 2.6 | 2.16 | -0.2 | -106.23 | |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | |
|||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| MARKET CAPITALIZATION | ||
| Listed Share | 840.000.000 | |
| Price | Rp. 386 | |
| Capitalization | Rp. 324 B. | |
| OWNERSHIP | ||
| Listing Date : 26-DEC-2018 | ||
| Lokal 97,05 % | Asing 0,04 % | Lainnya 2,91 % |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 0 | |
| Rating ROA | 0 | |
| Rating EQUITY | 1 | |
| Rating ROE | 0 | |
| Rating DER | 3 | |
| Rating TOTAL | 0 | |
RETURN ON ASSET
| PEHA - Phapros Tbk. | PEHA - Phapros Tbk. | PEHA - Phapros Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Board | : | 4 Index COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| TIME PERIOD : 11-10-2024 | |||
| Close | 386 | Prev Close | 380 |
| Change | 6 (1.6%) | Range | 380-386 |
| Bid | 380 | Offer | 384 |
| Bid Volume | 1000 | Offer Volume | 11000 |
| Frequency | 19 | Value Rp.: 10.433.800 | |
| RETURN ON ASSET | |||||
|---|---|---|---|---|---|
| Benchmark to Others : | |||||
| A Exceptional | |||||
| B Excellent | |||||
| C Very Good | |||||
| D Good | |||||
| E Fair | |||||
| F Poor | |
||||
| RATIO (%) | ≤ 0 |
0-0.4 | 0.4- 1.7 |
1.7- 3.6 |
> 3.6 |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | |
|||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
